DR. JEFFREY FRANK BONADIO, M.D.
Medical Practice at Tarantella Ln, San Diego, CA
License number
California G87022
Category
Medical Practice
Type
Anatomic Pathology
Address
Address
4680 Tarantella Ln, San Diego, CA 92130
Phone
(858) 525-1977
Personal information
See more information about JEFFREY FRANK BONADIO at radaris.comName
Address
Phone
4680 Tarantella Ln, San Diego, CA 92130
4505 Sunset Bluffs Way, San Diego, CA 92130
Professional information
Dr. Jeffrey F Bonadio, San Diego CA - MD (Doctor of Medicine)
Specialties:
Anatomic Pathology
Address:
4680 Tarantella Ln, San Diego 92130
(858) 525-1977 (Phone)
(858) 525-1977 (Phone)
Certifications:
Anatomic Pathology, 2007
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Medical College of Wisconsin
Graduated: 1979
Medical College of Wisconsin
Graduated: 1979
Methods Of Using Latent Tgf- Binding Proteins
US Patent:
6774105, Aug 10, 2004
Filed:
Jun 12, 2000
Appl. No.:
09/592685
Inventors:
Jeffrey Bonadio - San Diego CA
Wushan Yin - Ann Arbor MI
Wushan Yin - Ann Arbor MI
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
G01N 3353
US Classification:
514 12, 530350, 435 71
Abstract:
Disclosed are novel nucleic acid and peptide compositions comprising latent TGF binding proteins (LTBPs). Also disclosed are methods of using LTBP-2 and LTBP-3 peptides and the DNA segments which encode them.
Sustained Dna Delivery From Structural Matrices
US Patent:
7427602, Sep 23, 2008
Filed:
Nov 18, 1999
Appl. No.:
09/442542
Inventors:
Lonnie D. Shea - Evanston IL, US
Jeffrey Bonadio - San Diego CA, US
David J. Mooney - Ann Arbor MI, US
Martin C. Peters - Ann Arbor MI, US
Jeffrey Bonadio - San Diego CA, US
David J. Mooney - Ann Arbor MI, US
Martin C. Peters - Ann Arbor MI, US
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
A61N 43/04, A61K 63/00, A61K 9/14, A61K 45/00, A61F 13/00, C12P 21/06, C12N 15/00, C12N 5/00, A61K 38/00
US Classification:
514 44, 424 931, 424422, 424484, 424 851, 435 691, 4353201, 435325, 435455, 514 2, 514 54
Abstract:
Disclosed are particular 3-dimensional structural matrices containing nucleic acids, various fabrication processes and methods for the prolonged release of nucleic acids in various biological environments. The nucleic acid-matrix materials are created such that they maintain a defined space, allowing cellular migration, transfection and proliferation to occur in a controlled manner. The fabrication processes provide for both high incorporation efficiencies and control over the sustained nucleic acid release. The resultant nucleic acid-containing structural matrices are thus particularly useful in in vivo cell transfection and gene expression in the context of gene therapy.